Wuhan Hvsen Biotechnology Co Ltd Cash Flow Quality Index
Wuhan Hvsen Biotechnology Co Ltd cash flow quality index. Wuhan Hvsen Biotechnology Co Ltd (300871) has a Cash Flow Quality Index of 0.84x as of September 2025. Operating cash flow of CN¥59.06 Million is below net income of CN¥70.72 Million, suggesting accrual-heavy earnings not yet converted to cash. See Wuhan Hvsen Biotechnology Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Wuhan Hvsen Biotechnology Co Ltd (2016–2025)
Cash flow quality index of Wuhan Hvsen Biotechnology Co Ltd from 2016 to 2025. Historical Cash Flow Quality Index for Wuhan Hvsen Biotechnology Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Wuhan Hvsen Biotechnology Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Wuhan Hvsen Biotechnology Co Ltd Cash Flow Quality Index by Year (2016–2025)
Wuhan Hvsen Biotechnology Co Ltd cash flow quality index by year from 2016 to 2025. Year-by-year earnings quality comparison for Wuhan Hvsen Biotechnology Co Ltd. For the full cash flow conversion analysis, see Wuhan Hvsen Biotechnology Co Ltd cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.94x | CN¥238.45 Million | CN¥253.16 Million | ▼ -83.0% |
| 2023 | 5.54x | CN¥92.92 Million | CN¥16.78 Million | ▲ +201.9% |
| 2022 | 1.83x | CN¥96.68 Million | CN¥52.71 Million | ▲ +56.5% |
| 2021 | 1.17x | CN¥155.72 Million | CN¥132.87 Million | ▲ +264.0% |
| 2020 | 0.32x | CN¥48.35 Million | CN¥150.16 Million | ▼ -79.0% |
| 2019 | 1.53x | CN¥105.24 Million | CN¥68.77 Million | ▲ +418.0% |
| 2018 | 0.30x | CN¥21.10 Million | CN¥71.40 Million | ▼ -67.6% |
| 2017 | 0.91x | CN¥80.56 Million | CN¥88.41 Million | ▼ -25.0% |
| 2016 | 1.21x | CN¥60.00 Million | CN¥49.40 Million | — |